Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of YIC therapeutic vaccine in HBeAg-positive chronic hepatitis B
ChiCTR-TRC-07000019Phase 3Completed
- Sponsor
- Beijing Institute of Biological Products
- Start
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of YIC in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing Institute of Biological Products. Primary endpoint: Virological response. Started Oct 2007; status: completed.
02
Drugs
YIC
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-07000019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-07000019.